Cargando…

HCV Genome-Wide Genetic Analyses in Context of Disease Progression and Hepatocellular Carcinoma

Hepatitis C virus (HCV) is a major cause of hepatitis and hepatocellular carcinoma (HCC) world-wide. Most HCV patients have relatively stable disease, but approximately 25% have progressive disease that often terminates in liver failure or HCC. HCV is highly variable genetically, with seven genotype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donlin, Maureen J., Lomonosova, Elena, Kiss, Alexi, Cheng, Xiaohong, Cao, Feng, Curto, Teresa M., Di Bisceglie, Adrian, Tavis, John E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117537/ https://www.ncbi.nlm.nih.gov/pubmed/25079603 http://dx.doi.org/10.1371/journal.pone.0103748

Ejemplares similares

Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients
por: Donlin, Maureen J., et al.
Publicado: (2010)

Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics
por: Tavis, John E, et al.
Publicado: (2011)

Identification of 4-isopropyl–thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation
por: Elagawany, Mohamed, et al.
Publicado: (2018)

Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy
por: Cannon, Nathan A., et al.
Publicado: (2008)

A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity
por: Counts, Christopher J., et al.
Publicado: (2015)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Transcriptomic Data Analyses Reveal a Reprogramed Lipid Metabolism in HCV-Derived Hepatocellular Cancer
por: Liu, Guoqing, et al.
Publicado: (2020)

Synthesis and Evaluation of Troponoids as a New Class of Antibiotics
por: Cao, Feng, et al.
Publicado: (2018)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
por: Sun, Suofeng, et al.
Publicado: (2019)

Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development
por: Lange, Christian M., et al.
Publicado: (2013)

Reply to Itoh et al., “Potential Use of Iron-Limiting Therapy against Cryptococcus neoformans and Effects of Caspofungin on the Host Immune System”
por: Donlin, Maureen J.
Publicado: (2022)

A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame
por: Yao, Ermei, et al.
Publicado: (2005)

Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma
por: Gupta, Priyanka, et al.
Publicado: (2014)

NK cell function and receptor diversity in the context of HCV infection
por: Gardiner, Clair M.
Publicado: (2015)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
por: Goncharova, I.A., et al.
Publicado: (2023)

Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV
por: Mosa, Alexander I., et al.
Publicado: (2020)

Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression
por: Song, Guohe, et al.
Publicado: (2020)

HCV infection-associated hepatocellular carcinoma in humanized mice
por: Wang, Zhao, et al.
Publicado: (2015)

The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma
por: El-Daly, Usama M, et al.
Publicado: (2020)

Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022)

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
por: Welzel, Tania M, et al.
Publicado: (2017)

Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
por: Hetta, Helal F., et al.
Publicado: (2020)

Identification of prognostic miRNA-mRNA regulatory network in the progression of HCV-associated cirrhosis to hepatocellular carcinoma
por: Han, Liping, et al.
Publicado: (2022)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma
por: Badami, Ester, et al.
Publicado: (2022)

Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
por: Wagoner, Jessica, et al.
Publicado: (2011)

Cryptococcus at Work: Gene Expression during Human Infection
por: Upadhya, Rajendra, et al.
Publicado: (2014)

CpG Island Methylation of Suppressor of Cytokine Signaling-1 Gene Induced by HCV Is Associated With HCV-Related Hepatocellular Carcinoma
por: Liu, Miao, et al.
Publicado: (2022)

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
por: Canini, Laetitia, et al.
Publicado: (2017)

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
por: Sumie, Shuji, et al.
Publicado: (2011)

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
por: De Giorgi, Valeria, et al.
Publicado: (2009)

Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
por: De Giorgi, Valeria, et al.
Publicado: (2013)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
por: Fasolato, Silvano, et al.
Publicado: (2020)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs
por: Serio, Ilaria, et al.
Publicado: (2019)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

Comprehensive analysis of key lncRNAs in HCV-positive hepatocellular carcinoma
por: Liu, Jingqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lfci4epkmb9e7odac8mos387gf